If you are unsure what to do, contact your clinical team before taking any action
Youve likely heard about the incredible results of GLP-1 (glucagon-like peptide-1) medications, such as semaglutide, liraglutide, and tirzepatide, for weight loss in obese and overweight patients and type 2 diabetes mellitus
Early on Tschp noticed that obese mice lost weight when infused with one of DiMarchi's new glucagon peptides
Factors That May Affect Your Starting Dose Starting dose and escalation speed are influenced by BMI, renal and hepatic function, gastrointestinal history, concomitant glucose-lowering medications, and age
That can make diagnosing and dealing with side effects one of the most common and most important roles for GLP-1 nutritional counseling experts
The rest of this explains why it happens, what the actual numbers look like, and what helps